NRAS G13D
|
Multiple Myeloma
|
NRAS G13D
|
Multiple Myeloma
|
bortezomib Sensitive: D – Preclinical
|
bortezomib Sensitive: D – Preclinical
|
NRAS G13D
|
Melanoma
|
NRAS G13D
|
Melanoma
|
atezolizumab + HM95573 Sensitive: D – Preclinical
|
atezolizumab + HM95573 Sensitive: D – Preclinical
|
NRAS G13D
|
Mantle Cell Lymphoma
|
NRAS G13D
|
Mantle Cell Lymphoma
|
ASN007 Sensitive: D – Preclinical
|
ASN007 Sensitive: D – Preclinical
|